Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Umer Raffat
Pharma
Analysts to Gilead CEO: What's your plan to monetize remdesivir?
Just a day after remdesivir posted positive data, analysts hounded Gilead's CEO with one key question: When will the drug start making money?
Carly Helfand
Apr 30, 2020 8:28pm
Allergan preparing to split after years of turmoil: analyst
Jun 19, 2019 10:50am
BMS-Celgene integration questions? Execs aren't answering
Apr 26, 2019 11:45am
'Old guard' generics players yield U.S. scripts lead
Apr 18, 2019 12:06pm
Already delayed in lung cancer, BMS pulls crucial Opdivo filing
Jan 24, 2019 12:24pm
Pfizer, Merck topped the Dow in 2018 despite biopharma declines
Jan 2, 2019 11:33am
